AlphaStocks
5.1
Consider Buy

McKesson Corp (MCK)

As of Sep 20, 2026, McKesson Corp (MCK) scores 5.1/10 on AlphaStocks' five-model composite, #106 of 168 Health Care stocks. At $875, MCK trades 13% below its model fair value of $1,001.

Health Care / Health Care Distributors

S&P 500

$875.15

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#106out of 168 in Health Care

Is MCKESSON CORP a Good Investment in 2026?

MCKESSON CORP (MCK) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates MCKESSON CORP as Attractive (5/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. MCKESSON CORP currently trades 13% below its estimated fair value of $1,001. MCKESSON CORP ranks #106 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.8ROE-274.5Market Cap109B

Estimated Fair Value

$1,000.7913% below

Trading below estimated fair value. EPS grew 49% year-over-year. P/E of 23x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

PEG 1.6 · Stalwart

Greenblatt

Neutral

Earnings yield 6.1% · ROC 10%

Frequently Asked Questions

Is MCKESSON CORP (MCK) a good investment?
As of Sep 20, 2026, McKesson Corp (MCK) scores 5.1/10 on AlphaStocks' five-model composite, #106 of 168 Health Care stocks. At $875, MCK trades 13% below its model fair value of $1,001. That score is below average, suggesting caution.
What is MCKESSON CORP's Piotroski F-Score?
MCKESSON CORP's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MCK overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $1,001, MCK appears undervalued. The stock currently trades 13% below its estimated fair value. Trading below estimated fair value. EPS grew 49% year-over-year. P/E of 23x is moderate for this quality level.
How does MCK compare to other Health Care stocks?
MCKESSON CORP ranks #106 out of 168 stocks in the Health Care sector, placing it in the top 63% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about MCK?
AlphaStocks evaluates MCK using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.1/10.

Similar Stocks

CAHHSICCOR

Compare MCK with

CAH vs MCKHSIC vs MCKCOR vs MCKMCK vs PARRMCK vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer